Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 1995Clinical Transplantation

Antiviral prophylaxis and the Epstein Barr virus‐related post‐transplant lymphoproliferative disorder

View Full Paper
Ask AI
Bookmark
Share

Authors

CDConnie L. DavisCentre for Social InnovationKHKaren HarrisonUniversity of LincolnJMJohn P. McVicarUniversity of California Davis Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Davis et al. (1995) studied this question.

synapsesocial.com/papers/6a7def09cecc27a187a152b9https://doi.org/10.1111/j.1399-0012.1995.tb00297.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1IMMUNOHISTOLOGY OF EPSTEIN-BARR VIRUS-ASSOCIATED ANTIGENS IN B CELL DISORDERS FROM IMMUNOCOMPROMISED INDIVIDUALS1990 · 209 citations
  2. 2EPSTEIN-BARR VIRUS, IMMUNODEFICIENCY, AND B CELL LYMPHOPROLIFERATION1985 · 412 citations